Osvaldo Daniel Messina

2.5k total citations
53 papers, 1.3k citations indexed

About

Osvaldo Daniel Messina is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Osvaldo Daniel Messina has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Orthopedics and Sports Medicine, 15 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Osvaldo Daniel Messina's work include Bone health and osteoporosis research (19 papers), Bone Metabolism and Diseases (14 papers) and Bone health and treatments (12 papers). Osvaldo Daniel Messina is often cited by papers focused on Bone health and osteoporosis research (19 papers), Bone Metabolism and Diseases (14 papers) and Bone health and treatments (12 papers). Osvaldo Daniel Messina collaborates with scholars based in Argentina, United States and Netherlands. Osvaldo Daniel Messina's co-authors include Willem F. Lems, Patricia Clark, Kenneth G. Saag, Piet Geusens, Ronald Emkey, Nicola Pannacciulli, Jonathan D. Adachi, Cristiano A. F. Zerbini, Rosa Maria Rodrigues Pereira and Roland Chapurlat and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Osvaldo Daniel Messina

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osvaldo Daniel Messina Argentina 18 530 425 392 355 225 53 1.3k
Swan Sim Yeap Malaysia 18 544 1.0× 433 1.0× 278 0.7× 176 0.5× 155 0.7× 53 1.3k
M. Varenna Italy 23 670 1.3× 378 0.9× 357 0.9× 227 0.6× 224 1.0× 67 1.8k
Akihide Nampei Japan 16 350 0.7× 409 1.0× 215 0.5× 357 1.0× 71 0.3× 38 1.2k
Thomas Funck‐Brentano France 22 347 0.7× 919 2.2× 342 0.9× 606 1.7× 104 0.5× 57 1.7k
Giuseppe Girasole Italy 12 591 1.1× 212 0.5× 650 1.7× 805 2.3× 246 1.1× 21 1.7k
Robin K. Dore United States 14 727 1.4× 511 1.2× 662 1.7× 639 1.8× 129 0.6× 33 1.6k
Αθανάσιος Παπαθεοδώρου Greece 22 375 0.7× 158 0.4× 563 1.4× 460 1.3× 121 0.5× 90 1.6k
Kwi Young Kang South Korea 21 305 0.6× 677 1.6× 109 0.3× 247 0.7× 143 0.6× 66 1.3k
Paul Ryan United Kingdom 20 244 0.5× 297 0.7× 249 0.6× 263 0.7× 153 0.7× 36 1.3k
L. Achemlal Morocco 22 820 1.5× 396 0.9× 165 0.4× 194 0.5× 190 0.8× 54 1.3k

Countries citing papers authored by Osvaldo Daniel Messina

Since Specialization
Citations

This map shows the geographic impact of Osvaldo Daniel Messina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osvaldo Daniel Messina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osvaldo Daniel Messina more than expected).

Fields of papers citing papers by Osvaldo Daniel Messina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osvaldo Daniel Messina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osvaldo Daniel Messina. The network helps show where Osvaldo Daniel Messina may publish in the future.

Co-authorship network of co-authors of Osvaldo Daniel Messina

This figure shows the co-authorship network connecting the top 25 collaborators of Osvaldo Daniel Messina. A scholar is included among the top collaborators of Osvaldo Daniel Messina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osvaldo Daniel Messina. Osvaldo Daniel Messina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neyro, José Luís, et al.. (2024). Climacteric and fibromyalgia: a review. Climacteric. 27(5). 458–465. 1 indexed citations
2.
Harvey, Nicholas C., Kate A. Ward, D. Agnusdei, et al.. (2024). Optimisation of vitamin D status in global populations. Osteoporosis International. 35(8). 1313–1322. 12 indexed citations
3.
Otón, Teresa, et al.. (2024). The patient journey of fibromyalgia in Latin America. Reumatología Clínica (English Edition). 20(1). 32–42. 3 indexed citations
4.
Messina, Osvaldo Daniel. (2024). Comentarios sobre el tratamiento de la osteoporosis por corticoides. Reumatología Clínica. 20(2). 113–113. 1 indexed citations
5.
Otón, Teresa, et al.. (2023). El viaje del paciente con fibromialgia en Latinoamérica. Reumatología Clínica. 20(1). 32–42.
6.
Messina, Osvaldo Daniel, Giovanni Adami, Luis Vidal, et al.. (2023). Chronic arthritides and bone structure: focus on rheumatoid arthritis—an update. Aging Clinical and Experimental Research. 35(7). 1405–1416. 7 indexed citations
7.
8.
Cannata‐Andía, Jorge B., Natalia Carrillo‐López, Osvaldo Daniel Messina, et al.. (2021). Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?. Nutrients. 13(11). 3835–3835. 23 indexed citations
9.
Geusens, Piet, Bert van Rietbergen, Osvaldo Daniel Messina, et al.. (2020). Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment. Journal of Bone and Mineral Research. 37(6). 1136–1146. 10 indexed citations
10.
Saag, Kenneth G., Rachel B. Wagman, Piet Geusens, et al.. (2018). Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. The Lancet Diabetes & Endocrinology. 6(6). 445–454. 136 indexed citations
11.
Messina, Osvaldo Daniel, et al.. (2018). Osteoporosis: a clinical and pharmacological update. Clinical Rheumatology. 38(2). 385–395. 43 indexed citations
12.
Schurman, León, A.M. Galich, Claudio González, et al.. (2017). [Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015].. PubMed. 77(1). 46–60. 7 indexed citations
13.
Collado, Antonio, Xavier Torres, Osvaldo Daniel Messina, et al.. (2015). The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries. Pain Medicine. 17(5). 931–939. 6 indexed citations
14.
Torres, Xavier, Antonio Collado, Osvaldo Daniel Messina, et al.. (2013). The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability. Lara D. Veeken. 52(12). 2283–2291. 10 indexed citations
15.
Schurman, León, A. Bagur, Osvaldo Daniel Messina, et al.. (2013). Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis. SHILAP Revista de lepidopterología. 73(1). 55–74. 18 indexed citations
16.
Bianchi, M.L., Antonio Bossi, Danuta Chlebna‐Sokół, et al.. (2005). An international registry of fragility fractures in the young. Bone. 1 indexed citations
17.
Sen, Shuvayu S., Osvaldo Daniel Messina, Jorge Morales‐Torres, et al.. (2005). A risk assessment tool (OsteoRisk) for identifying latin American women with osteoporosis. Journal of General Internal Medicine. 20(3). 245–250. 35 indexed citations
18.
Sen, Saugata, Olga Geling, Osvaldo Daniel Messina, et al.. (2002). Comparison of body weight and body mass index as predictors for osteoporosis among postmenopausal latin american women. Open Repository and Bibliography (University of Liège). 3 indexed citations
19.
Sarris, A H, K. O. Kliche, A. Preti, et al.. (1999). Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Annals of Oncology. 10(4). 433–440. 132 indexed citations
20.
Messina, Osvaldo Daniel, et al.. (1997). Site-dependent bone mineral density response to oral pamidronate and calcium in postmenopausal osteoporosis: A preliminary report. Clinical Rheumatology. 16(4). 346–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swan Sim Yeap Breakdown of academic impact, for papers by M. Varenna Breakdown of academic impact, for papers by Akihide Nampei Breakdown of academic impact, for papers by Thomas Funck‐Brentano Breakdown of academic impact, for papers by Giuseppe Girasole Breakdown of academic impact, for papers by Robin K. Dore Breakdown of academic impact, for papers by Αθανάσιος Παπαθεοδώρου Breakdown of academic impact, for papers by Kwi Young Kang Breakdown of academic impact, for papers by Paul Ryan Breakdown of academic impact, for papers by L. Achemlal
Rankless by CCL
2026